Xtant Medical (NYSEAMERICAN:XTNT) Share Price Crosses Above 200-Day Moving Average – What’s Next?

Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.68 and traded as high as $0.6870. Xtant Medical shares last traded at $0.63, with a volume of 332,254 shares trading hands.

Wall Street Analyst Weigh In

Separately, BTIG Research dropped their target price on shares of Xtant Medical from $2.00 to $1.50 and set a “buy” rating on the stock in a research note on Tuesday, November 11th. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $1.50.

Xtant Medical Price Performance

The firm has a fifty day moving average of $0.69 and a 200 day moving average of $0.68. The company has a current ratio of 2.21, a quick ratio of 1.06 and a debt-to-equity ratio of 0.35. The company has a market capitalization of $88.20 million, a P/E ratio of 63.06 and a beta of -0.08.

Xtant Medical (NYSEAMERICAN:XTNT) last announced its quarterly earnings results on Monday, November 10th. The medical device company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. Xtant Medical had a net margin of 1.32% and a return on equity of 3.77%. The firm had revenue of $27.77 million for the quarter, compared to the consensus estimate of $32.70 million.

Hedge Funds Weigh In On Xtant Medical

Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Xtant Medical by 4.6% in the third quarter. Vanguard Group Inc. now owns 2,355,671 shares of the medical device company’s stock worth $1,529,000 after acquiring an additional 104,159 shares during the period. Mink Brook Asset Management LLC boosted its position in Xtant Medical by 125.8% in the second quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company’s stock worth $81,000 after purchasing an additional 60,997 shares during the last quarter. AWM Investment Company Inc. bought a new stake in shares of Xtant Medical during the 2nd quarter valued at about $4,875,000. Nantahala Capital Management LLC increased its position in shares of Xtant Medical by 500.3% during the 2nd quarter. Nantahala Capital Management LLC now owns 68,394,000 shares of the medical device company’s stock valued at $50,543,000 after purchasing an additional 57,000,000 shares during the last quarter. Finally, Jane Street Group LLC bought a new position in shares of Xtant Medical in the 2nd quarter worth approximately $26,000. 69.33% of the stock is owned by institutional investors.

Xtant Medical Company Profile

Xtant Medical, Inc is a medical technology company focused on the development, manufacturing and distribution of bone graft, spine biologics and related implantable medical devices. The company’s product portfolio is designed to address critical needs in spinal fusion, orthopedics and trauma surgery by providing a range of solutions that promote bone growth, structural support and patient recovery.

The company’s offerings include an array of bone graft substitutes – such as demineralized bone matrix putties and fibers – interbody fusion devices, spinal fixation systems and biologic agents.